BridgeBio Pharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has BridgeBio Pharma's balance sheet done over the years? Its assets were worth $546,380,000 last year, which is less than in the previous period. 346% of BridgeBio Pharma’s total assets is currently financed by debt. Its liabilities reached the amount of $1,888,915,000, which means an increase by 1% compared compared to last year.
Debt to Assets
| 2017 | 98044000 | 152.72M | 155.78% |
|---|---|---|---|
| 2018 | 464941000 | 566.44M | 121.83% |
| 2019 | 631679000 | 155.70M | 24.65% |
| 2020 | 703588000 | 595.70M | 84.67% |
| 2021 | 1012792000 | 1.87B | 185.46% |
| 2022 | 623036000 | 1.86B | 299.82% |
| 2023 | 546380000 | 1.88B | 345.71% |
BBIO Balance Sheet (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | 375.93M | 376.68M | 393.77M | 356.08M | 363.77M | 436.08M | 91.99M |
Short term investments | 58.94M | 95.23M | 442.89M | 251.01M | 182.22M | 0 | 0 |
Net receivables | 1.75M | 17.07M | 19.74M | 0 | 0 | 0 | 0 |
Inventory | 0 | 37.93M | -68.89M | 0 | 0 | 0 | 0 |
Other current assets | 40.95M | 21.92M | 101.34M | 35.73M | 22.62M | 2.05M | 5.13M |
Total current assets | 477.59M | 505.2M | 839.71M | 642.82M | 599.76M | 445.22M | 97.13M |
Non-current assets: | |||||||
Property, Plant and Equipment | 19.84M | 25.24M | 45.97M | 36.83M | 5.62M | 1.57M | 440K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 26.31M | 28.71M | 44.93M | 0 | 0 | 0 | 0 |
Long term investments | 0 | 43.65M | 49.14M | 2.6M | 31.14M | 17.05M | 381K |
Other non-current assets | 22.62M | 20.22M | 33.02M | 21.33M | -4.85M | 1.09M | 92K |
Total non-current assets | 68.78M | 117.83M | 173.08M | 60.76M | 31.91M | 19.71M | 913K |
Total assets | 546.38M | 623.03M | 1.01B | 703.58M | 631.67M | 464.94M | 98.04M |
Liabilities | |||||||
| Current liabilities: | |||||||
Accounts payable | |||||||
Deferred revenue | 6.09M | 8.15M | 0 | 75.9M | 31.45M | 0 | 0 |
Short term debt | 8.25M | 3.67M | 4.93M | 1.45M | 8M | 0 | 0 |
Total current liabilities | 143.84M | 117.75M | 130.13M | 91.85M | 52.38M | 32.57M | 8.55M |
| Non-current liabilities: | |||||||
Long term debt | 1.73B | 1.72B | 1.72B | 494.32M | 99.79M | 54.50M | 143.86M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 9.36M | 26.64M | 22.06M | 9.52M | 3.52M | 479.36M | 312K |
Total non-current liabilities | 1.74B | 1.75B | 1.74B | 503.84M | 103.31M | 533.86M | 144.17M |
Total liabilities | 1.88B | 1.86B | 1.87B | 595.70M | 155.70M | 566.44M | 152.72M |
| Data source | Data source | Data source | Data source | Data source |